Free Trial

Allegion (NYSE:ALLE) Releases FY 2025 Earnings Guidance

Allegion logo with Industrials background

Allegion (NYSE:ALLE - Get Free Report) updated its FY 2025 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of 8.000-8.150 for the period, compared to the consensus estimate of 7.838. The company issued revenue guidance of -.

Analysts Set New Price Targets

Several brokerages have recently weighed in on ALLE. Wells Fargo & Company raised their price target on Allegion from $150.00 to $175.00 and gave the company an "equal weight" rating in a report on Friday. Mizuho lifted their price objective on Allegion from $145.00 to $155.00 and gave the stock a "neutral" rating in a report on Friday. The Goldman Sachs Group lifted their price objective on Allegion from $149.00 to $170.00 and gave the stock a "buy" rating in a report on Tuesday, July 8th. Robert W. Baird lifted their price objective on Allegion from $150.00 to $175.00 and gave the stock a "neutral" rating in a report on Friday. Finally, Morgan Stanley lifted their price objective on Allegion from $139.00 to $151.00 and gave the stock an "equal weight" rating in a report on Friday, July 11th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and two have assigned a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of "Hold" and an average target price of $164.57.

Get Our Latest Report on Allegion

Allegion Stock Performance

NYSE:ALLE traded up $1.80 on Friday, hitting $165.47. The stock had a trading volume of 1,446,818 shares, compared to its average volume of 914,092. The stock has a market cap of $14.24 billion, a price-to-earnings ratio of 22.98, a price-to-earnings-growth ratio of 4.06 and a beta of 1.01. The company has a quick ratio of 1.51, a current ratio of 2.30 and a debt-to-equity ratio of 1.14. The business's 50-day simple moving average is $144.55 and its two-hundred day simple moving average is $135.49. Allegion has a 52-week low of $116.57 and a 52-week high of $166.22.

Allegion (NYSE:ALLE - Get Free Report) last announced its earnings results on Thursday, July 24th. The scientific and technical instruments company reported $2.04 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.00 by $0.04. The business had revenue of $1.02 billion for the quarter, compared to analysts' expectations of $999.10 million. Allegion had a return on equity of 42.62% and a net margin of 16.15%. The business's revenue for the quarter was up 5.8% on a year-over-year basis. During the same period last year, the firm posted $1.96 earnings per share. As a group, research analysts predict that Allegion will post 7.77 earnings per share for the current year.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in ALLE. Focus Partners Wealth lifted its position in shares of Allegion by 204.5% during the 1st quarter. Focus Partners Wealth now owns 7,186 shares of the scientific and technical instruments company's stock valued at $937,000 after buying an additional 4,826 shares in the last quarter. NewEdge Advisors LLC lifted its position in shares of Allegion by 35.3% during the 1st quarter. NewEdge Advisors LLC now owns 3,272 shares of the scientific and technical instruments company's stock valued at $427,000 after buying an additional 854 shares in the last quarter. Empowered Funds LLC lifted its position in shares of Allegion by 13.0% during the 1st quarter. Empowered Funds LLC now owns 5,673 shares of the scientific and technical instruments company's stock valued at $740,000 after buying an additional 651 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in shares of Allegion by 7.0% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 9,592 shares of the scientific and technical instruments company's stock valued at $1,251,000 after buying an additional 626 shares in the last quarter. Finally, Jones Financial Companies Lllp lifted its position in shares of Allegion by 44.2% during the 1st quarter. Jones Financial Companies Lllp now owns 1,629 shares of the scientific and technical instruments company's stock valued at $213,000 after buying an additional 499 shares in the last quarter. 92.21% of the stock is owned by hedge funds and other institutional investors.

About Allegion

(Get Free Report)

Allegion plc manufactures and sells mechanical and electronic security products and solutions worldwide. The company offers door controls and systems and exit devices; locks, locksets, portable locks, and key systems and services; electronic security products and access control systems; time, attendance, and workforce productivity systems; doors, accessories, and other.

See Also

Earnings History and Estimates for Allegion (NYSE:ALLE)

Should You Invest $1,000 in Allegion Right Now?

Before you consider Allegion, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Allegion wasn't on the list.

While Allegion currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Stocks to BUY NOW in August 2025
The $2.5B Merger No One Is Talking About
ALERT: Big Tech Earnings – Watch Before Wednesday

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines